ARCHIVES

Michael Friedman To Head PhRMA’s Office Of Biomedical Preparedness.

This article is from The Cancer Letter archive.

Vol. 27 No. 40 | November 2, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires

September 9, 1994

Penn Begins Clinical Trial Of A Vaccine For Breast Cancer Based On Telomerase

February 27, 2004

Holden Center At U. Of Iowa Designated Comprehensive.

January 26, 2001

Neutron Therapy “Treatment Of Choice” In Salivary Gland Tumors – 100 Percent Complete Reponses

June 13, 1986

ASCO Releases Three Guidelines For Cancer Survivorship Care

April 25, 2014

Study: Routine CT Not Needed In Detecting DLBCL Remissions

May 31, 2013